Research interests
Gene therapy for vascular disease and DNA decoy molecule research[20]
Victor J. Dzau
Commencement address at the University of Michigan
As of 2025 · Last known relationship
Commencement address at the University of Michigan
As of 2025 · Last known relationship
Childhood as a refugee of the Chinese Civil War
Victor J. Dzau matters as a cardiovascular physician-scientist and academic health leader whose work spans vascular biology, health-system leadership, and global health. He is James B. Duke Distinguished Professor of Medicine, Professor of Medicine and Pathology, Chancellor Emeritus at Duke University, and President of the National Academy of Medicine. His research interests include cardiology and molecular and genomic vascular receptor biology, with earlier work on renin-angiotensin biology, ACE inhibitors, tissue angiotensin systems, and vascular gene therapy. His career included cardiology training at Massachusetts General Hospital, leadership roles at Stanford and Harvard, and service as Duke’s Chancellor for Health Affairs and President and CEO of Duke University Health System from 2004 to 2014. Dzau has also described growing up as a refugee of the Chinese Civil War and advocates for health equity and global health.
Each topic is linked to its supporting source in Sources.
Training includes Commencement address at the University of Michigan, Commencement speech at Emory University, Duke Centennial oral history interview on his Duke leadership and the future of health care, and Chair, Health and Medicine Division, plus 48 more records.
Explore education and trainingAs of 2025
2025
As of 2024
As of 2024
As of 2018
As of 2016
As of 2016
2016
As of 2015
As of 2014
As of 2014
As of 2014
As of 2004
As of 2004
As of 2004
As of 2004
As of 1996
As of 1996
As of 1996
As of 1996
As of 1996
As of 1995
As of 1990
As of 1990
As of 1984
As of 1980
As of 1979
As of 1979
As of 1979
As of 1978
As of 1976
As of 1976
As of 1975
As of 1974
As of 1973
As of 2015
As of 2015
As of 2004
As of 2004
Gene therapy for vascular disease and DNA decoy molecule research[20]
Molecular and Genomic Vascular Receptor Biology[9]
Research on the renin-angiotensin-aldosterone system, ACE inhibitors, and the tissue angiotensin system[20]